Amoxicillin pharmacokinetics after intravenous administration were studied in patients with normal renal function, with impaired renal function, and during hemodialysis. The average urinary recovery was 68% in patients with normal renal function. Serum half-life was highly correlated (r = 0.967) with creatinine clearance corrected for body weight. Expected half-life was 71 min for a corrected creatinine clearance of 100 ml/min per 70 kg and 16 h in the anephric patient. Average amoxicillin half-life on hemodialysis was 3.6 h. We present a dosage nomogram for making appropriate adjustments to loading dose based on patient weight and maintenance dose based on corrected creatinine clearance.
Amoxicilmin is a new semisynthetic penicillin with a structure and antibacterial spectrum similar to ampicillin. Amoxicillin absorption is greater after oral administration, and penetration into the cerebral spinal fluid appears greater.
The objective of the present study was to characterize the pharmacokinetics of intravenously (i.v.) administered amoxicillin particularly as altered by impaired renal function. In addition, we sought to develop a simple, useful dosage strategy for administering amoxicillin to patients with varying degrees of renal impairment.
MATERIALS AND METHODS
The total number of subjects was 20, of whom 4 had normal renal function and 16 had chronic renal insufficiency. All subjects fasted on the evening preceding the test. Before the i.v. infusion, they received a standard breakfast (300 ml of decaffeinated coffee plus bread and jam without milk, butter, or cream).
At zero time (just before the i.v. injection), they emptied their bladders, and a blood sample was taken. Amoxicillin was injected by a bolus i.v. infusion over 1 min of 1 g diluted in 20 ml of 0.9% sodium chloride.
The subjects remained in a supine position during the first 6 h of the study and received no solid or liquid food; afterwards they were allowed normal dietary and physical activities.
The first four subjects ( Endogenous creatinine clearance (Cer) was determined on the same 24-h urine collection. The average of the serum creatinines measured at the beginning and end of the 24-h period was used in calculation of clearance.
Patients 5 to 20 were 19 to 74 years old and had various degrees of chronic renal insufficiency as determined from C,r. Four patients with chronic end-stage renal function were receiving periodic hemodialysis.
Blood samples were taken at the above times and also at 24, 36, and 48 h postinfusion. Five urine samples were collected (except for the dialysis group) as above and also at 24 to 36 and 36 to 48 h. The four dialysis patients were also studied during a hemodialysis session. Amoxicillin was administered immediately before the beginning of a 7-h hemodialysis session. Blood samples were taken at zero time (beginning of dialysis) and at 0.5, 1, 2, 3, 4, 5, 6, or 7 h postinfusion. Plated (Gambro) or coil (Travenol Ultra Flow 100) artificial kidneys were used with constant blood flow of 200 to 250 ml/min and dialysate flow of 800 ml/min. Antibiotic assays. Blood samples were immediately centrifuged for 10 min at 4,000 rpm. Urines were filtered under sterile conditions (filters, Millipore Corp.) as soon as collected. Sera and urines were refrigerated at -20°C until assayed.
The antimicrobial activity of amoxicillin in serum and urine was determined by the microbiological method of diffusion in agar by the technique described by Grove and Randall (7) and modified by Chabbert and Boulingre (2) . The test strain used was Sarcina lutea 5345 (Pasteur Institute). Agar (Difco N2 at pH 6.6) was inoculated with 1 ml of bacterial suspension having an optical density of 0.090 at 650 nm. An 80-mil amount of this agar medium was poured onto a sterile glass plate. The sample to be analyzed was introduced into a 20-td well punched out of the agar. 28 VOL. 15, 1979 The standard reference concentrations of amoxicil- 
Initial parameter estimates were provided by exponential peeling, and an iterative least-squares method was used to find the elimination rate constant (K.), central volume of distribution (Va), and intercompartment rate constants (K12 and K21) which best described the observed serum levels for each subject (13) . As an initial step in the analysis, individual plots were generated for each patient and examined by the authors. The V, was examined for correlation with measured weight, body surface area (BSA) (6) , and lean body weight (LBW) by least-squares linear regression. We considered LBW to be expected weight for the obese subjects as suggested by Hull and Sarubbi (8) . Expected weight was determined from the Geigy table of average weights (5) .
The total volume of distribution at steady state (V8) is defined as follows:
V.8 = VC X (1 + K12/K21) (2) V,. was also examined for correlation with the above measurements of patient size (weight, LBW, and BSA).
Furthermore, because we were seeking a simple, useful dosage strategy, we examined the beta-phase volume or single-compartment approximation, Vb (14), as follows:
Regression analysis was performed and scatter plots examined were for Vb versus weight, LBW, and BSA. The clearance of compounds which are largely excreted unchanged by the kidney depends on C,r (1, 4).
Thus, we examined the correlation between K. and the endogenous Ccr. The K, for a drug depends on the ratio of the clearance of the drug and the volume of distribution (12) . Thus, we examined the predictive value of the ratio of Ccc to BSA, LBW, and measured weight, respectively, by linear regression as above. Likewise, we examined the correlation of beta with parameter beta on C,, as well as Ccc corrected for LBW, BSA, and measured weight.
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RESULTS
The results of the two-compartment pharnacokinetic analysis are summarized in Table 1 . Figure 1 shows the average serum concentrations for four groups according to renal function. Figure 2 illustrates the effect of hemodialysis on drug clearance.
The distribution phase showed an average alpha of 2.6/h. The distribution half-life is thus 16 min. The average urinary recovery from the four patients with CorC,, > 100 ml/min per 70 kg was 68%. Average urinary concentrations were 1,420 ,ug/ml per 0 to 6 h and 307 ,ug/ml per 6 to 12 h.
Volume of distribution. There was no expected or observed effect of renal function on the volume parameters, so all 19 subjects were examined as a single group. Amoxcillin half-life. There is a clear reduction in Ke and beta with decreasing Ccr (Table  1) . The correlations between the elimination rate constants (K., beta) and renal function (Cc, corrected Cc,'s) are summarized in Table 3 . For both K. and beta, the maximum correlation occurs when Ccr is corrected for measured weight, which we define as the corrected creatinine clearance (CorCcr), as follows:
CorCc, = (Cc, x 70)/weight (4) Figure 3 shows the linear regression for beta on CorCc,. The est correlation occurs with correction for weight relation between the dose in a 70-kg patient and (70/weight), but for the sample size of four, the the expected peak serum amoxicilhin level. rThe correlation coefficient, r = 0.839, has an associ-appropriate loading dose depends only on target ated P value of 0.162.
or desired dose and weight. It is calculated by Dosage nomogram. The adjustment of dose locating the patient's weight (bar 1), the desired for patient size and renal function can be accom-dose (bar 2), and extending a straight line to the plished with an alignment chart (Fig. 4) by draw-recommended loading dose (bar 3). ing two straight lines. The desired dose would
The maintenance dose is chosen to replace be best specified in terms of serum drug level, the amount of drug lost during the dosage interbut as a practical matter physician experience is val and thus depends on the loading dose and with a "usual dose" (e.g., 500 mg or 1 g every 6 drug half-life. A line connecting the loading dose h) in a "standard" patient (70 kg; Cc, 100 (bar 3) and CorCcr (bar 5) will give the best ml/min).
estimate of the correct maintenance dose (bar The second bar of the nomogram shows the 4). 
